Ipsen operates in 115 countries. The Group's largest R&D and manufacturing sites are located in China, France, Ireland, the United Kingdom and the United States.
Click on the map to find out more about our strategic sites:
27 August 2014 - Basking Ridge (USA)
Ipsen North America Announces Second Resupply of Increlex® (mecasermin [rDNA origin] Injection) in the U.S. in 2014